Continuous low-dose cytokine infusion therapy

Details Continuous low-dose cytokine infusion therapy Continuous low-dose cytokine infusion therapy

A - Human Necessities

61

K

A61K 47/48 (2006.01) A61K 38/19 (2006.01) A61K 38/21 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2329474

A chronic hepatitis C antiviral pharmaceutical composition comprises an antivirally effective amount of a polymer-cytokine conjugate in association with a pharmaceutically acceptable carrier, the cytokine may be, for example, interferon alpha or interferon alpha-2b, and the polymer of the conjugate may be, for example, polyethylene glycol.

Affiliated with

Also associated with

Rating

Continuous low-dose cytokine infusion therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Continuous low-dose cytokine infusion therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Continuous low-dose cytokine infusion therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2023217